Publication | Open Access

Autoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigen

Prognostic BiomarkersUrologyMedicineProteomicsPathologyBenign Prostatic HyperplasiaBiostatisticsBiomarker DiscoveryProstatic DiseaseMolecular Diagnostics